These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18568563)

  • 21. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
    van Baardwijk A; Bosmans G; Boersma L; Buijsen J; Wanders S; Hochstenbag M; van Suylen RJ; Dekker A; Dehing-Oberije C; Houben R; Bentzen SM; van Kroonenburgh M; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):771-8. PubMed ID: 17398018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.
    Yoshikawa H; Randall EK; Kraft SL; Larue SM
    Vet Radiol Ultrasound; 2013; 54(3):307-13. PubMed ID: 23441633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
    Kajitani C; Asakawa I; Uto F; Katayama E; Inoue K; Tamamoto T; Shirone N; Okamoto H; Kirita T; Hasegawa M
    J Radiat Res; 2013 Jul; 54(4):671-8. PubMed ID: 23287772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
    Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
    Bundschuh RA; Andratschke N; Dinges J; Duma MN; Astner ST; Brügel M; Ziegler SI; Molls M; Schwaiger M; Essler M
    Strahlenther Onkol; 2012 Jul; 188(7):592-8. PubMed ID: 22441441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
    Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
    Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
    Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.
    Greco C; Nehmeh SA; Schöder H; Gönen M; Raphael B; Stambuk HE; Humm JL; Larson SM; Lee NY
    Am J Clin Oncol; 2008 Oct; 31(5):439-45. PubMed ID: 18838879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.
    Wang D; Schultz CJ; Jursinic PA; Bialkowski M; Zhu XR; Brown WD; Rand SD; Michel MA; Campbell BH; Wong S; Li XA; Wilson JF
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):143-51. PubMed ID: 16618577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
    Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.
    Riegel AC; Berson AM; Destian S; Ng T; Tena LB; Mitnick RJ; Wong PS
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):726-32. PubMed ID: 16626888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.